Q: I follow Jason Donville and like 5iresearch recommends similar tech companies as 5i using "the rule of 40". Do you use this rule? Other than his fairly transparent newsletter, is there any way to see exactly what his holdings are in the DKAM Capital Ideas fund?
Q: Hi, with the announcement of Dialogue's future IPO, can you explain the differences between these 4 companies? Also, do you know the date of Dialogue's IPO?
Q: Could you please comment on VHI's latest licensing deal.
Thanks as always.
VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a multi-year large-scale licensing transaction of recently acquired subsidiary Intouch with Health’s (“Intouch”) Synopsis product with South Tees Hospitals NHS Foundation Trust (the “Trust” or “South Tees”).
This transaction is among VitalHub’s largest to-date, comprising a 5-year licensing contract for the Company’s proprietary, award-winning Synopsis platform. From initial questionnaire through to post-operative outcomes, Synopsis provides the necessary tools to enable hospitals to manage the entire pre-operative assessment process digitally – removing paper trails, increasing data security, and delivering significant organizational and economic benefits.
Q: Hi, I would like to reduce the number of stocks in my portfolio. I have small positions in these 3 stocks. In what order should I sell them and is any worth keeping?
Thanks.
Q: First of all, thanks for the service you provide. I have found it extremely useful since becoming a member. Second, I apologize for the number of stocks covered in the question. If it is too many, please do not respond / post.
Within the last 12 months, I have purchased the above stocks strictly for growth or as momentum plays.
I would like to know which ones you would sell, either because their momentum has likely peaked, or because their share price growth prospects are poor. Please deduct as many credits as required. Thanks
Q: Happy New Year to Everyone at 5i and thanks for all your guidance.
I have just taken profits in XBC (thanks) in my TSFA and would like your purchase a similar small cap growth stock. I already have STC, Well and Pho. Could you please give me 3-4 suggestions.
Thanks
Dave.
I currently own WELL, however I'm looking at at three others in the space, Vitalhub, cloudMD and Think Research.
Please give me an over view of the differentiation between these four.
Also your view, rank, on which of the four will be the best in 5 yrs.
Thx
Q: Do you endorse a tax-loss sale for these three stocks, DXCM, REAL, VHI with the intention to buy back after 30 days? Are there any that you wouldn't buy back and instead use the proceeds on another high growth name such as NVDA, U, GOOS, PINS, MGNI? Sector weighting is not a concern and risk tolerance is high. Thanks.
I need to sell some of my shares in these companies to fund another investment. Of the stocks listed, in what order would you be inclined to sell first? Thank you.
Q: Good morning, could you please rank these 10 small caps that the team has mentioned recently in terms of both opportunity (highest to lowest) and risk (Lowest to highest). I am unfamiliar with DCM but from your comments, and the extremely low PE, I am assuming they owe a few bucks? Could you shed some light on the company? Thx as always for tremendous guidance.
Q: Could you please comment on vital health earning report and future prospects. Is it a hold / sell / or buy more? Could you also comment dynacert hold / sell / buy more)?
Q: I am looking to add your suggestions of Palantir and Pinterest. Can you please rank them with some of my current 5i holdings in terms of growth highest to lowest and risk highest to lowest. These are 1-2 percent fringe plays and I have a balanced portfolio so I am not worried about cap size, geographic location etc. Thanks very much as always for advice.